BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,023,000 | -17.0% | 111,833 | +50.4% | 1.65% | -21.3% |
| Q2 2022 | $7,254,000 | -17.0% | 74,344 | -34.1% | 2.10% | -2.1% |
| Q1 2022 | $8,742,000 | -15.4% | 112,747 | -6.3% | 2.14% | -11.2% |
| Q4 2021 | $10,333,000 | +5.5% | 120,372 | -1.2% | 2.41% | -1.5% |
| Q3 2021 | $9,797,000 | +8.1% | 121,808 | +8.2% | 2.45% | +13.6% |
| Q2 2021 | $9,063,000 | -14.1% | 112,578 | -10.0% | 2.16% | -13.4% |
| Q1 2021 | $10,551,000 | +0.5% | 125,104 | -4.3% | 2.49% | -1.8% |
| Q4 2020 | $10,495,000 | +2.1% | 130,791 | +2.3% | 2.53% | -4.5% |
| Q3 2020 | $10,282,000 | -8.9% | 127,851 | -2.4% | 2.65% | -4.2% |
| Q2 2020 | $11,284,000 | +1.6% | 131,057 | -4.2% | 2.77% | -3.9% |
| Q1 2020 | $11,104,000 | -8.1% | 136,761 | -5.4% | 2.88% | +26.7% |
| Q4 2019 | $12,084,000 | -3.6% | 144,510 | +0.8% | 2.28% | -8.8% |
| Q3 2019 | $12,537,000 | +4.9% | 143,329 | -1.8% | 2.49% | +11.9% |
| Q2 2019 | $11,948,000 | +1.1% | 145,890 | +0.3% | 2.23% | -1.3% |
| Q1 2019 | $11,822,000 | +22.7% | 145,389 | -0.7% | 2.26% | +16.3% |
| Q4 2018 | $9,636,000 | -30.3% | 146,402 | -18.3% | 1.94% | -17.7% |
| Q3 2018 | $13,818,000 | +0.2% | 179,239 | -4.1% | 2.36% | -7.3% |
| Q2 2018 | $13,796,000 | +13.3% | 186,837 | -0.2% | 2.54% | +8.5% |
| Q1 2018 | $12,180,000 | -2.4% | 187,263 | -3.0% | 2.34% | -1.2% |
| Q4 2017 | $12,481,000 | +0.0% | 193,084 | -2.9% | 2.37% | +9.7% |
| Q3 2017 | $12,475,000 | +27.5% | 198,804 | +23.0% | 2.16% | +2.7% |
| Q2 2017 | $9,787,000 | -13.2% | 161,667 | -25.6% | 2.11% | -13.2% |
| Q1 2017 | $11,269,000 | -7.1% | 217,302 | -20.5% | 2.43% | -15.6% |
| Q4 2016 | $12,125,000 | -21.6% | 273,447 | -15.8% | 2.88% | -3.5% |
| Q3 2016 | $15,457,000 | -4.5% | 324,723 | -9.3% | 2.98% | +1.2% |
| Q2 2016 | $16,192,000 | +10.6% | 358,068 | +0.5% | 2.95% | +8.3% |
| Q1 2016 | $14,642,000 | +12.0% | 356,415 | +4.0% | 2.72% | +10.3% |
| Q4 2015 | $13,072,000 | +6.7% | 342,647 | +12.3% | 2.47% | +8.5% |
| Q3 2015 | $12,248,000 | -50.8% | 305,057 | -14.3% | 2.28% | -39.2% |
| Q2 2015 | $24,903,000 | +11.0% | 356,112 | +8.8% | 3.74% | +13.1% |
| Q1 2015 | $22,427,000 | -9.3% | 327,403 | -3.0% | 3.31% | -6.3% |
| Q4 2014 | $24,731,000 | +5.1% | 337,438 | +2.9% | 3.53% | +4.5% |
| Q3 2014 | $23,529,000 | -3.6% | 327,845 | -2.8% | 3.38% | +9.1% |
| Q2 2014 | $24,397,000 | +18.3% | 337,444 | +20.4% | 3.10% | +21.9% |
| Q1 2014 | $20,629,000 | – | 280,359 | – | 2.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |